Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study

Abstract

Surgery for recurrent glioblastoma can be beneficial in selected patients and carries an acceptable morbidity rate. The pattern of recurrence influenced PPS and the NIH Recurrent GBM Scale was a reliable prognostication tool.